What is the share price of CCME Global Ltd (CCME) today?
The share price of CCME as on 30th October 2026 is ₹33.70. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on CCME Global Ltd (CCME) share?
The past returns of CCME Global Ltd (CCME) share are- Past 1 week: 11.52%
- Past 1 month: -22.87%
- Past 3 months: -70.54%
- Past 6 months: -70.03%
- Past 1 year: -79.17%
- Past 3 years: 244.46%
- Past 5 years: 329.58%
What are the peers or stocks similar to CCME Global Ltd (CCME)?
The peers or stocks similar to CCME Global Ltd (CCME) include:What is the market cap of CCME Global Ltd (CCME) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of CCME Global Ltd (CCME) is ₹657.89 Cr as of 30th October 2026.What is the 52 week high and low of CCME Global Ltd (CCME) share?
The 52-week high of CCME Global Ltd (CCME) is ₹184.90 and the 52-week low is ₹26.41.What is the PE and PB ratio of CCME Global Ltd (CCME) stock?
The P/E (price-to-earnings) ratio of CCME Global Ltd (CCME) is -926.60. The P/B (price-to-book) ratio is 16.42.Which sector does CCME Global Ltd (CCME) belong to?
CCME Global Ltd (CCME) belongs to the Health Care sector & Biotechnology sub-sector.How to buy CCME Global Ltd (CCME) shares?
You can directly buy CCME Global Ltd (CCME) shares on Tickertape. Simply sign up, connect your demat account and place your order.
CCME Global Ltd
CCME Share Price
BSECCME Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
CCME Performance & Key Metrics
CCME Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -773.99 | 16.42 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 45.82 | 5.76 | 0.50% |
CCME Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
CCME Company Profile
Genesis IBRC India Ltd is a biotechnology company focused on developing and marketing microbial and antimicrobial products for aquaculture, agriculture, poultry, and animal husbandry sectors.
CCME Forecast
CCME Forecasts
CCME
CCME
Income
Balance Sheet
Cash Flow
CCME Income Statement
CCME Income Statement
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 3.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.00 | ||||||||||
| Operating & Other expenses | 3.69 | 0.10 | 0.02 | 0.03 | 0.02 | 0.12 | 0.06 | 0.03 | 0.54 | 0.24 | ||||||||||
| EBITDA | -3.69 | -0.10 | 3.65 | -0.03 | -0.02 | -0.12 | -0.06 | -0.03 | -0.50 | -0.24 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | ||||||||||
| PBIT | -3.69 | -0.10 | 3.65 | -0.03 | -0.02 | -0.12 | -0.06 | -0.03 | -0.50 | -0.26 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBT | -3.69 | -0.10 | 3.65 | -0.03 | -0.02 | -0.12 | -0.06 | -0.03 | -0.50 | -0.26 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Net Income | -3.69 | -0.10 | 3.65 | -0.03 | -0.02 | -0.12 | -0.06 | -0.03 | -0.50 | -0.26 | ||||||||||
| EPS | -2.84 | -0.07 | 2.81 | -0.02 | -0.02 | -0.09 | -0.05 | -0.02 | -0.37 | -0.06 |
CCME Company Updates
CCME Stock Peers
CCME Past Performance & Peer Comparison
CCME Past Performance & Peer Comparison
Health CareBiotechnology
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| CCME Global Ltd | -926.60 | 16.42 | — |
| Biocon Limited | 148.41 | 1.56 | 0.14% |
| Anthem Biosciences Limited | 78.92 | 15.35 | 0.24% |
| Sai Life Sciences Limited | 94.85 | 13.32 | — |
CCME Stock Price Comparison
Compare CCME with any stock or ETFCCME Holdings
CCME Shareholdings
CCME Promoter Holdings Trend
CCME Promoter Holdings Trend
CCME Institutional Holdings Trend
CCME Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
CCME Shareholding Pattern
CCME Shareholding Pattern
CCME Shareholding History
CCME Shareholding History
smallcases containing CCME stock
smallcases containing CCME stock
Looks like this stock is not in any smallcase yet.
CCME Events
CCME Events
CCME Dividend Trend
CCME has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
CCME Dividend Trend
CCME has not given any dividends in last 5 years
CCME Dividends
CCME Dividends
CCME Stock News & Opinions
CCME Stock News & Opinions
CCME Global Limited is expanding its presence in the Middle East and Africa through the acquisition of stakes in Cash & Carry Middle East FZCO (CCME UAE) and Cash & Carry Middle East FZCO, both based in Dubai, United Arab Emirates, and engaged in FMCG trading and distribution. The company acquired a 45% stake in CCME UAE for 11,25,00,000 shares of CCME Global Limited, valued at INR 112.50 crore, while also acquiring 2,25,000 shares of CCME UAE for the same value. These transactions, classified as related party transactions due to the involvement of CCME Global Limited’s directors and promoters, were valued by Independent Registered Valuer and Akasam Consulting Private Limited. As of June 30, 2026, CCME UAE reported a turnover of AED 6,90,25,527 and a net profit of AED 43,98,509; shareholder and audit committee approvals have been obtained, with FEMA filings still required.
CCME Global Limited has acquired a 45% stake in Cash & Carry Middle East FZCO (CCME UAE), a Dubai-based trading and distribution company specializing in FMCG products for the Middle East and Africa, for approximately $135 million USD. The acquisition, completed October 28, 2026, involved the issuance of 2,25,000 shares of CCME Global Limited and establishes CCME UAE as an associate company. CCME UAE reported a turnover of AED 69,025,527 (approximately $1.88 million USD) and a net profit of AED 43,98,509 (approximately $1.19 million USD) as of June 30, 2026. The transaction, considered to be conducted at arm’s length, expands CCME Global Limited’s presence in the Middle East and African markets and leverages CCME UAE’s existing customer base, with the acquisition involving related parties holding a majority stake in the target company.
CCME Global Limited, formerly known as Genesis IBRC India Limited, informed BSE Limited that it received a certificate from Venture Capital And Corporate Investments Private Limited, its Registrar and Transfer Agent, confirming compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
CCME Global Limited, formerly Genesis IBRC India Limited, announced a significant share issuance to acquire stakes in CCME and Interlink, alongside a share sub-division and relocation of its registered office. The company issued 19,60,92,244 shares, valued at INR 196,09,22,440, for the CCME acquisition and 2,03,42,244 shares, valued at INR 2,03,42,24,400, for a 52% stake in Interlink. To enhance liquidity, CCME Global plans a 1:10 share split, reducing the face value per share from INR 10 to INR 1, expected to be completed in fiscal year 2026-2027. The company is also relocating its registered office from Eluru, Andhra Pradesh, to Mumbai, Maharashtra, to align with its operational and management functions. Poonam Chaturvedi serves as Managing Director, and contact information is available at www.genesisiil.com and csgenesisiil@gmail.com.
CCME Global Limited, formerly known as Genesis IBRC India Limited, announced several corporate actions in a filing with the stock exchange, including the acquisition of a 52% stake in Interlink and another stake in CCME Global Limited through a share-based transaction, significantly increasing the company’s share capital. Shareholders have approved a 1:10 stock split, reducing the face value of each share from INR 10 to INR 1, expected to be completed during the fiscal year 2026-2027 to enhance liquidity and accessibility. Additionally, the company is relocating its registered office from Eluru, Andhra Pradesh, to Mumbai, Maharashtra, to align with its current operational structure, requiring an amendment to its Memorandum of Association. The moves reflect the company’s growth strategy and operational efficiency initiatives.
CCME Global Limited, formerly Genesis IBRC India Limited, announced several corporate actions in a filing with the stock exchange. The company issued 2,03,42,244 equity shares to acquire a 52% stake in Interlink and an undisclosed stake in CCME. Shareholders will also see a 1:10 share sub-division, reducing the face value of each share from Rs 10 to Rs 1, expected to be completed in the current fiscal year ending FY 2026-2027. Additionally, the company is relocating its registered office from Eluru, Andhra Pradesh, to Mumbai, Maharashtra, and amending its Memorandum of Association accordingly. The share split requires BSE approval and will result in a significant increase in the number of outstanding shares, from 19,60,92,244 to 196,09,22,440. Poonam Chaturvedi, Managing Director, signed the filing.
CCME Global Limited, formerly Genesis IBRC India Limited, has announced several significant corporate actions including the acquisition of stakes in Interlink and CCME Global Limited, each involving a 52% share acquisition through a consideration other than cash. The company is also planning a 1:10 share split, reducing the face value per share from INR 10 to INR 1, with completion expected in fiscal year 2026-2027 to enhance liquidity and encourage broader investor participation. Furthermore, CCME Global Limited is relocating its registered office from Eluru, Andhra Pradesh, to Mumbai, Maharashtra, and amending its Memorandum of Association accordingly. The company’s authorized share capital is INR 200 crore, with a pre-split issued and subscribed capital of INR 196.09 crore and a paid-up capital of INR 196.09 crore. Poonam Chaturvedi serves as Managing Director.
CCME Global Limited, formerly Genesis IBRC India Limited, has allotted 20,342,244 equity shares to acquire a 52% stake in Interlink, with Mr. Mostafa Ahmed Kabir as a key shareholder receiving the shares. The company has also approved a 1:10 stock split, reducing the face value of each share from INR 10 to INR 1, expected to be completed in the current fiscal year 2026-2027 to enhance liquidity and accessibility for smaller investors. Additionally, CCME Global is relocating its registered office from Eluru, Andhra Pradesh, to Mumbai, Maharashtra, to align with its operational center. The changes, including the acquisition and relocation, were approved by shareholders at the 34th Annual General Meeting, and the company’s authorized, issued, subscribed, and paid-up share capital remain at INR 200,00,00,000, INR 196,09,22,440, and INR 196,09,22,440 respectively, before and after the split. Poonam Chaturvedi, Managing Director, signed the disclosure document.
CCME Global Limited, formerly known as Genesis IBRC India Limited, will close its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of its unaudited standalone financial results for the second quarter and half year of fiscal year 2026-2027 ending September 30, 2026, according to a filing with the BSE Limited.
CCME Global Limited, formerly known as Genesis IBRC India Limited, will close its Register of Members and Share Transfer Books from Wednesday, September 23, 2026, to Tuesday, September 29, 2026, for its 34th Annual General Meeting scheduled for Tuesday, September 29, 2026, at 3:00 p.m. (IST).
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant